NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Metware Biotechnology

Metware Biotechnology

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://metwarebio.com/

Last Round

Series B

Apr 2, 2024

Total Funding Raised

$15.49M

Company Overview

Metware Biotechnology is a biotechnology company that provides multi-omics services, including proteomics, metabolomics, and lipidomics, for academic research, clinical studies, and pharmaceutical development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Freemium

AI Layer

Application

Keywords

metabolomics servicescontract research organizationCROwidely-targeted metabolomicsproteomics servicesmulti-omics analysisomics CROlipidomics servicesbiomarker discoverybioinformatics servicesmetabolite databasedrug discovery supportomics data analysisclinical trial supportuntargeted spatial metabolomicsagricultural biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Metware Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Metware Biotechnology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Metware Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 2, 2024
Series ASep 24, 2021
AngelSep 22, 2017
View all Funding Rounds

Metware Biotechnology Investors

Notable investors and investment history

Metware Biotechnology investors
InvestorRounds
HongShanSeries A
Wuhan Institute of BiotechnologyAngel
Tianjin Haida Venture Capital ManagementSeries B
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 45% MoM.

  • Jun 1, 2025

    Monthly visitors increased 55% MoM.

View all signals

Metware Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Metware Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Metware Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range19
Year Founded2015
Last FundingApr 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.